Jonathan Edelson is a Respiratory physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3900 N Buffalo St
Orchard Park, NY 141271842
Telephone
716-656-4482Provider last certified this registry record 25 Mar 2026.
Clinical trials
- Motivational Interviewing and Group Heart Transplant Exercise and Education: A Pilot Study
Sponsor: Children's Hospital of Philadelphia
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
- GENZYME CORPORATIONProgram year20251 payment
- Inspire Medical Systems, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
59.2%Corticosteroid32.4%Trelegy Ellipta49%Breztri Aerosphere13%Fluticasone Propionate13%Breo Ellipta10%Budesonide-Formoterol Fumarate7%Symbicort5%Breyna2%Arnuity Ellipta2%Part D<11 patientsbeta2-Adrenergic Agonist23.8%Albuterol Sulfate Hfa96%Ventolin Hfa4%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
25.8%Corticosteroid25.2%Prednisone100%Part D≥444 patientsProton pump inhibitor0.6%Omeprazole100%Part D<11 patientsAnti-infectives
12.5%Macrolide Antimicrobial8.8%Azithromycin100%Part D≥223 patientsTetracycline-class Drug2.9%Doxycycline Hyclate100%Part D≥71 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”